* Painless hepatomegaly and splenomegaly: the size of the spleen can be 1500–3000 g, as opposed to the normal size of 50–200 g. Splenomegaly may decrease the affected individual's capacity for eating by exerting pressure on the stomach. While painless, enlargement of spleen increases the risk of splenic rupture. * Hypersplenism and pancytopenia, the rapid and premature destruction of blood cells, leads to anemia, neutropenia, leukopenia, and thrombocytopenia (with an increased risk of infection and bleeding). * Cirrhosis of the liver is rare. * Severe pain associated with joints and bones occurs, frequently presenting in hips and knees. * Neurological symptoms occur only in some types of<unk> 's (see below): * Type I: impaired olfaction and cognition * Type II: serious convulsions, hypertonia, intellectual disability, and apnea * Type III: muscle twitches known as myoclonus, convulsions, dementia, and ocular muscle apraxia * Parkinson's disease is recognized as being more common in<unk>  patients and their heterozygous carrier relatives. * Osteoporosis: 75% of patients develop visible bony abnormalities due to the accumulated glucosylceramide. A deformity of the distal femur in the shape of an Erlenmeyer flask is commonly described. * Yellowish-brown skin pigmentation
Gaucher's disease
Glycogen storage disease type III
Glycogen storage disease type 0
Glycogen storage disease type IX
Glycogen storage disease type IV
Glycogen storage disease type I
Glycogen storage disease type II
Glycogen storage disease type VI